4 nominees · 3 ballot items.
Elect four directors; approve the Natural Health Trends Corp. 2026 Equity Incentive Plan (1,100,000 shares); and ratify appointment of CBIZ CPAs P.C. as independent registered public accounting firm for the year ending December 31, 2026.
Election of four (4) nominees to the Board of Directors to serve until the next annual meeting of stockholders (Randall A. Mason, Ellen Sun, Ching C. Wong, and Chris T. Sharng).
Approve the 2026 Equity Incentive Plan, which would replace the expiring 2016 plan and reserve 1,100,000 shares for awards to employees, officers, directors, contractors, consultants, and advisors worldwide.
This management proposal requests shareholder approval of the Natural Health Trends Corp. 2026 Equity Incentive Plan, a broad-based compensation vehicle that would replace the company’s expiring 2016 plan and reserve up to 1,100,000 shares for future awards to employees, officers, directors and service providers worldwide. Management seeks approval to preserve its ability to attract, retain and motivate personnel and to align employee incentives with shareholder value through options, stock awards, stock units and stock appreciation rights, subject to administrator discretion and specified safeguards. The plan includes governance controls such as administration by the Compensation Committee, limits on repricing without shareholder approval, and a $500,000 annual cap on aggregate grant-date fair value plus cash fees to any non-employee director. Board materials disclose that the requested share reserve is smaller than the number of shares available under the expiring 2016 plan and that the company’s three-year average burn rate is low relative to industry metrics, which management cites to argue the grant request is modest. The Equity Plan permits performance-based vesting and includes customary anti-dilution adjustments, change-in-control provisions, transferability limitations, and recovery/recoupment provisions. Tax and compliance features are addressed (including Code Sections 162(m) and 409A considerations) and the plan contemplates incentive and nonstatutory stock options, stock appreciation rights, stock units and stock grants. The Board recommends a vote FOR because it views equity awards as critical to competitive compensation, and it highlights plan limits and administrative discretion intended to mitigate dilution and governance risk. For a sophisticated evaluation, key considerations include the absolute share reserve (1.1M), the plan’s potential dilution (~12.8% as disclosed), the administrator’s broad discretion over award terms and substitutions, and whether the disclosed burn-rate and director caps adequately protect long-term shareholders versus management retention needs.
Ratify the Audit Committee’s appointment of CBIZ CPAs P.C. as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 6.47% | 555,415 | $2M |
| 2 | BlackRock, Inc. | 1.11% | 95,576 | $267K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.04% | 88,867 | $248K |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 0.89% | 76,604 | $214K |
| 5 | VANGUARD FIDUCIARY TRUST CO | 0.41% | 34,905 | $97K |
| 6 | CITADEL ADVISORS LLC | 0.39% | 33,414 | $93K |
| 7 | STATE STREET CORP | 0.31% | 27,012 | $75K |
| 8 | DIMENSIONAL FUND ADVISORS LP | 0.27% | 23,303 | $65K |
| 9 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 22,600 | $63K |
| 10 | BlackRock, Inc. | 0.22% | 19,050 | $53K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.